Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415) - Lorenzen, Sylvie; Schwarz, Alix; Pauligk, Claudia; Goekkurt, Eray; Stocker, Gertraud; Knorrenschild, Jorge Riera; Illerhaus, Gerald; Dechow, Tobias; Moehler, Markus; Moulin, Jean-Charles; Pink, Daniel; Stahl, Michael; et al. (BMC Cancer, 2023)